Skip to main content
Caplight Logo









Nervotec

Nervotec

Private
SingaporeHealthcare & Life Scienceshttps://nervotec.com

Last Round

Seed

May 31, 2023

Company Overview

Nervotec operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Seed round in May 2023.

Nervotec is a healthcare technology company that develops contactless, remote health parameter measurement software using rPPG technology and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, InsurTech, Telemedicine

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Nervotec Comparables

Compare Nervotec with similar companies based on industry and business-model similarity.

Nervotec comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shen AI
91%
NuraLogix
91%
PanopticAI
90%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Nervotec Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 31, 2023
AcceleratorNov 8, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Nervotec Investors

Notable investors and investment history

Nervotec investors
InvestorRounds
Mercatus CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2022

    Received funding from Huawei Cloud.

Book a demo to see all signals

For institutional investors. Book with your work email.

Nervotec Filings

Explore SEC and related filing metadata, where available.

Nervotec filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Nervotec's valuation, stock price, and market status.

Is Nervotec a public or private company?

Nervotec is a private company.

What is the current stock price of Nervotec?

Nervotec is a private company, so its shares have no public market price. Caplight tracks Nervotec's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Nervotec worth (valuation)?

Valuation information for Nervotec is not publicly available.

Can I buy Nervotec stock?

Nervotec shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Nervotec's last funding round?

Nervotec's most recent funding round was Seed on May 31, 2023.

Who are the main investors in Nervotec?

Key investors in Nervotec include Mercatus Capital.

Will Nervotec IPO soon?

No public IPO plans have been announced for Nervotec.

How can I track Nervotec secondary market activity?

Caplight tracks bids, offers, and trades in Nervotec's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range7
Year Founded2020
Last FundingMay 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?